image
Healthcare - Biotechnology - NASDAQ - US
$ 7.77
-5.08 %
$ 459 M
Market Cap
-2.82
P/E
BALANCE SHEET
622 M ASSETS
28.43%
31.5 M LIABILITIES
3.99%
590 M EQUITY
30.11%
BALANCE SHEET DECOMPOSITION
Balance Sheet Cullinan Oncology, Inc.
image
Current Assets 415 M
Cash & Short-Term Investments 399 M
Receivables 0
Other Current Assets 15.7 M
Non-Current Assets 207 M
Long-Term Investments 204 M
PP&E 2.35 M
Other Non-Current Assets 366 K
64.16 %32.88 %Total Assets$621.8m
Current Liabilities 30.6 M
Accounts Payable 1.68 M
Short-Term Debt 1.3 M
Other Current Liabilities 27.7 M
Non-Current Liabilities 849 K
Long-Term Debt 0
Other Non-Current Liabilities 849 K
5.34 %4.13 %87.83 %Total Liabilities$31.5m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 83.0 98.4 550.1 430.9 168.2 63.2 33.8
Short Term Investments 316.0 368.6 311.1 230.7 42.0 35.4 0
Receivables 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0
Other Current Assets 15.7 13.1 7.2 12.2 4.1 1.5 0.4
Total Current Assets 414.7 480.2 474.5 296.6 212.3 100.1 34.2
PP&E 2.4 3.5 5.3 77 K 0.1 0.2 0.2
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 204.4 0 80.9 140.4 0 0 0
Other Long Term Assets 0.4 0.5 0.5 0.1 2.3 0.2 0.2
Other Assets 0 0 0 0 0 0 0
Total Assets 621.8 484.2 561.1 437.2 214.7 100.5 34.6
LIABILITIES
Accounts Payable 1.7 2.5 2.7 3.2 9.7 0.9 0.3
Short Term Debt 1.3 1.4 1.6 0 0 0 0
Other Current Liabilities 8.3 24.2 14.0 8.6 4.6 1.6 1.0
Total Current Liabilities 30.6 28.1 22.5 11.7 14.3 2.5 1.3
Long Term Debt 0 2.1 3.6 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 0 0 0 65 K 74 K 137.8 54.0
Total Liabilities 31.5 30.3 26.1 11.8 291.0 140.4 55.3
EQUITY
Common Stock 6 K 4 K 5 K 4 K 1 K 1 K 1 K
Retained Earnings (368.2) (200.9) (47.7) (158.9) (93.3) (41.5) (20.9)
Other Accumulative Comprehensive Income/Loss (0.1) (0.1) (2.6) (0.8) 2 K 4 K 1 K
Total Equity 590.3 453.9 535.0 423.0 (76.3) (39.9) (20.6)
Total Liabilities and Equity 621.8 484.2 561.1 434.8 214.7 100.5 34.6
SHARES OUTSTANDING
Common Shares Outstanding 53.8 41.5 45.2 44.3 43.5 43.5 11.4